SCHEMBL12601656

SCHEMBL12601656

CC(=O)OC[C@H]1O[C@@H](c2ccc(Cl)c(CO[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)c2)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.56
▸ PTPN1 P18031 1/20 0.41
▸ CYP2D6 P10635 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ LMNA P02545 2/20 0.40
▸ CA2 P00918 7/20 0.39
▸ CA4 P22748 7/20 0.39
▸ CA5A P35218 7/20 0.39
▸ CA7 P43166 7/20 0.39
▸ CA5B Q9Y2D0 7/20 0.39
▸ CA12 O43570 6/20 0.39
▸ CA1 P00915 6/20 0.39
▸ CA6 P23280 4/20 0.39
▸ CA9 Q16790 4/20 0.39
▸ CA13 Q8N1Q1 4/20 0.39
▸ CA14 Q9ULX7 4/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ THRB P10828 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146654 0.91 TSHR (0.43) TSHRPTPN1
SCHEMBL239974 0.84 TSHR (0.55) TSHRPTPN1CYP2D6ALDH1A1MAPK1
SCHEMBL12649848 0.84 TSHR (0.55) TSHRPTPN1CYP2D6ALDH1A1MAPK1
SCHEMBL15888786 0.84 TSHR (0.55) TSHRPTPN1CYP2D6ALDH1A1MAPK1
SCHEMBL14782693 0.83 TSHR (0.63) TSHRPTPN1CYP2D6ALDH1A1MAPK1
SCHEMBL14247838 0.83 TSHR (0.63) TSHRPTPN1CYP2D6ALDH1A1MAPK1
SCHEMBL3787332 0.83 TSHR (0.63) TSHRPTPN1CYP2D6ALDH1A1MAPK1
SCHEMBL12649999 0.81 TSHR (0.64) TSHRPTPN1CYP2D6LMNACA2
SCHEMBL222652 0.81 TSHR (0.64) TSHRPTPN1CYP2D6LMNACA2
SCHEMBL12601659 0.81 TSHR (0.64) TSHRPTPN1CYP2D6LMNACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943788-B2 Including the antidiabetic, antiobesity sodium glucose transport inhibitor Canagliflozin (1-( beta -D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene) MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-05-17 — — US disclosed
Send feedback